BSEBoard Meeting4d ago · 4 Nov 2026, 04:52 pm

M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2026 and any other items with the permission of the chairman.

M. K. Proteins Ltd · 543919

✦ AI SummaryResults

M. K. Proteins Ltd has scheduled a Board Meeting on 13/11/2026 to consider and approve the Unaudited Financial Results for the quarter and half year ended 30th September 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

M. K. Proteins Ltd - 543919 - Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2026

Attachments (1)

📄

881517d6-7b6c-4487-aff3-b2ab3cf9e54c.pdf

pdf

Download →
View document text
Date: 04/11/2026 To To The Manager The Manager Listing Compliance Listing Compliance Bombay Stock Exchange Limited National Stock Exchange of India P.J.Towers, Dalal Street, Limited (NSE) Mumbai-400 001 Exchange Plaza, Bandra Kurla Complex, Maharashtra, India Bandra East, Mumbai – 400051 SCRIP CODE: 543919 NSE SYMBOL: MKPL Sub: Intimation of Board Meeting pursuant to regulation 29 of the SEBI(LODR) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby like to inform you that a meeting of the Board of Directors of the Company will be held on Friday, 13th November, 2026, inter alia, to consider and approve the following businesses: 1. The Un-audited Financial Results of the Company for the quarter and half year ended 30th September, 2026; 2. Any other items with the permission of the chairman. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct for prevention of Insider Trading (Code), the “Trading Window” for trading in Equity Shares of the Company will accordingly be re- opened after 48 hours from the declaration of the aforesaid Un-audited Financial Results. You are requested to take the above on record. Thanking you, Yours Truly, For M K Proteins Limited Neha Aggarwal Company Secretary & Compliance Officer M. K. Proteins Limited Naraingarh Road, Village Garnala, Ambala City(Haryana), India - 134003 T : 0171-2679358 I W: www.mkproteins.in I E: compliancemkproteins@gmail.com CIN : L15500HR2012PLC046239| ISIN : INE964W01021